de Bruijn Henriëtte S, Sluiter Wim, van der Ploeg-van den Heuvel Angélique, Sterenborg Henricus J C M, Robinson Dominic J
Center for Optical Diagnostics and Therapy, Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands.
Photodermatol Photoimmunol Photomed. 2006 Oct;22(5):238-46. doi: 10.1111/j.1600-0781.2006.00240.x.
BACKGROUND/PURPOSE: A significant increase in the number of circulating and tumour neutrophils immediately after therapy was observed while investigating the increase in response of tissues to aminolevulinic acid-based photodynamic therapy (ALA-PDT) using a twofold illumination scheme with a prolonged dark interval. The action of (tumour) neutrophils is an important therapeutic adjunct to the deposition of singlet oxygen within the treatment volume, for many photosensitizers. It is not known if those phagocytes contribute to the improved outcome of ALA-PDT. In this study we investigated the role of neutrophils in the response to PDT using systemic ALA with and without light fractionation.
Rhabdomyosarcoma, transplanted in the thigh of female WAG/Rij rats were illuminated transdermally using 633 nm light following i.v. administration of 200 mg/kg ALA. The pharmacokinetics of protoporphyrin IX (PpIX) within the tumour tissue during therapy were determined to compare with that observed in other models for topical administration of ALA. PDT was performed under immunologically normal or neutropenic conditions using various illumination schemes. The number of neutrophils in tumour and in the circulation were determined as a function of time after treatment and compared with growth delay of each scheme.
Fluorescence spectroscopy revealed similar pharmacokinetics of PpIX to those observed during and after topical ALA-PDT. The number of neutrophils within the illuminated tumour and in the circulation increased significantly following therapy. This increase in the number of neutrophils was associated with an increase in the efficacy of therapy: the more effective the therapy the greater the increase in tumour and blood neutrophils. Administration of anti-granulocyte serum treatment prevented the influx of neutrophils after ALA-PDT, but did not lead to a significant decrease in the efficacy of the PDT treatment on the growth of the tumour for any illumination scheme investigated.
These results indicate that the magnitude of damage inflicted on the tumour by ALA-PDT does not depend on the presence of neutrophils in the tumour or circulation and that the role of neutrophils in ALA-PDT is much less important than in PDT using other photosensitizers. These data contribute to the understanding of the mechanism of response of tissue to systemic ALA-PDT.
背景/目的:在使用具有延长暗间隔的双重光照方案研究组织对基于氨基乙酰丙酸的光动力疗法(ALA-PDT)的反应增加时,观察到治疗后循环和肿瘤中性粒细胞数量显著增加。对于许多光敏剂而言,(肿瘤)中性粒细胞的作用是单线态氧在治疗区域内沉积的重要治疗辅助手段。尚不清楚这些吞噬细胞是否有助于改善ALA-PDT的治疗效果。在本研究中,我们研究了中性粒细胞在使用全身ALA进行光动力疗法(PDT)且有或无分次照射时的反应中的作用。
将横纹肌肉瘤移植到雌性WAG/Rij大鼠的大腿中,在静脉注射200mg/kg ALA后,使用633nm光进行经皮照射。测定治疗期间肿瘤组织中原卟啉IX(PpIX)的药代动力学,以与其他ALA局部给药模型中观察到的情况进行比较。在免疫正常或中性粒细胞减少的条件下,使用各种光照方案进行PDT。测定治疗后肿瘤和循环中中性粒细胞的数量随时间的变化,并与每种方案的生长延迟进行比较。
荧光光谱显示PpIX的药代动力学与局部ALA-PDT期间和之后观察到的相似。治疗后,照射肿瘤内和循环中的中性粒细胞数量显著增加。中性粒细胞数量的增加与治疗效果的增加相关:治疗越有效,肿瘤和血液中性粒细胞的增加就越大。给予抗粒细胞血清治疗可防止ALA-PDT后中性粒细胞的流入,但对于所研究的任何光照方案,均未导致PDT治疗对肿瘤生长的疗效显著降低。
这些结果表明,ALA-PDT对肿瘤造成的损伤程度不取决于肿瘤或循环中中性粒细胞的存在,并且中性粒细胞在ALA-PDT中的作用比使用其他光敏剂的PDT中重要性要小得多。这些数据有助于理解组织对全身ALA-PDT反应的机制。